WhitehurstC, MooreJV.Development of an alternative light source to lasers for biomedical applications.International Society for Optical Engineering1996; 2629: 291–8.
4.
HeyerdahlH, WangI, LiuDL, Pharmacokinetic studies on 5 aminolaevulinic acid induced protoporphyrin IX accumulation in tumours and normal tissues.Cancer Lett1997; 112: 225–35.
5.
KreigmairM, BaumgartnerR, KnuechelRFluorescence photodetection of neoplastic urothelial lesions following intravesical administration of 5 aminolaevulinic acid.Urology1994; 44: 836–41.
6.
BaumgartnerR, HueberRM, SchulzHInhalation of 5 aminolaevulinic acid: a new technique for fluorescence detection of early stage lung cancer.J Photochem Photobiol B1996; 36: 169–74.
7.
StummerW, StockerS, WagnerSIntraoperative detection of malignant gliomas by 5 aminolaevulinic acid induced porphyrin fluorescence.Neurosurgery1998; 42: 518–25.
8.
PopkenG, WetterauerU, Schultze-SeemanW.Kidney preserving tumour resection in renal cell carcinoma with photodynamic detection by 5-ALA: preclinical and preliminary clinical studies.Br J Urol Int1999; 83: 578–82.
9.
CairnduffF, StringerMR, HudsonEJ, AshDV, BrownSB.Superficial photodynamic therapy with topical 5 ALA for superficial primary and secondary skin cancer.Br J Cancer1994; 69: 605–8.
10.
MortonCA, WhitehurstC, MoseleyH, McCollJH, MooreJV, MacKieRM.Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease.Br J Dermatol1996; 135: 766–71.
11.
NseyoUO, DeHavenJ, DoughertyTJPhotodynamic therapy in the treatment of patients with resistant superficial bladder cancer: a long term experience.J Clin Laser Med Surg1998; 16: 61–8.
12.
KreigmairM, BaumgartnerR, LumperW, WaidelichR, HofstetterA.Early clinical experience with 5 ALA for the photodynamic therapy of superficial bladder cancer.Br J Urol1996; 77: 667–71.
BarrH, ShepherdNA, DixA, RobertsDJH, TanWC, KrasnerN.Eradication of high grade dysplasia in columnar lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.Lancet1996; 348: 584–5.
15.
SchweitzerVG.Photodynamic therapy for the treatment of head and neck cancer.Otolaryngol Head Neck Surg1990; 102: 225–32.
16.
EllC, GossnerL, MayAPhotodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience.Gut1998; 43: 354–9.
17.
BownSG.New techniques in laser therapy.BMJ1998; 316: 754–7.
18.
PerriaC, CaraiM, FalzoiAPhotodynamic therapy of malignant brain tumours: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications.Neurosurg1988; 23: 557–63.
19.
BruceRA, McCaughanJS.Lasers in uveal melanoma.Ophthal Clin N Am1989; 2: 597–604.
20.
Schmidt-ErfurthU, MillerJ, SickenbergMPhotodynamic therapy of subfoveal choroidal neovascularisation: clinical and angiographic examples.Graefes Arch Clin Exp Ophthalmol1998; 236: 365–74.
21.
AdiliF, Statius van EpsRG, FlotteTJ, La MuragliaGM.Photodynamic therapy with local photosensitiser delivery inhibits experimental hyperplasia.Lasers Surg Med1998; 23: 263–73.
22.
BoehnckeWH, SterryW, KaufmannR.Treatment of psoriasis by topical photodynamic therapy with polychromatic light.Lancet1994; 343: 801.
23.
BissonnetteR, McCleanDI, ReidG, KelsallJ, LiuH.Photodynamic therapy of psoriasis and psoriatic arthritis with PBD (Verteporfin) [Abstract RC87]. 7th Biennial Congress of the International Photodynamic Association, 7–9 July 1998, Nantes, France.
24.
FehrMK, WyssP, TrombergBJSelective photosensitiser localisation in the human endometrium after intrauterine application of 5 ALA.Am J Obstet Gynecol1996; 175: 1253–9.